Patent ID: 11872311
Assignee: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 1:
2. The metal-bisphosphonate nanoparticle of claim 1, wherein the core further comprises a non-bisphosphonate therapeutic agent or prodrug thereof and/or an imaging agent, wherein the non-bisphosphonate therapeutic agent is selected from the group consisting of methotrexate, leucovorin, pemetrexed disodium, doxorubicin, vinblastine, vincristine, vindesine, cytarabine, azathioprine, melphalan, imatinib, anastrozole, letrozole, a photodynamic therapy agent, a radiosensitizer, a beta-emitting radionuclide, a protein, and a peptide.